$100 off any box of TXT Singles (12x24 or 12x30) + 2 Free Sterile PTFE Suture Samples

Facebook-f Linkedin-in Instagram Youtube

Meet the Osteogenics Team

Leadership

Shane Shuttlesworth

President

Bio

Liz Bastian

Director of Regulatory Affairs

Bio

Blake Baucum

Director of Sales

Bio

Courtney Riggan

Director of Engineering

Bio

Russ Rowan

Director of Marketing

Bio

Salem O'steen

Director of Quality Assurance

Bio

Evan Cain

Director of Research & Development

Bio

Anibal Manzo

Director of Channel Sales

Bio

About Osteogenics

Headquartered in Lubbock, Texas, Osteogenics Biomedical is a leader in the development of innovative dental bone grafting products serving periodontists, oral & maxillofacial surgeons, and clinicians involved in regenerative and implant dentistry throughout the world. Osteogenics offers a complete line of bone grafting products including: enCore® combination and mineralized allografts, Zcore™ porcine xenograft, Cytoplast™ PTFE membranes, Cytoplast™ RTM collagen membranes, Vitala™ porcine pericardium collagen membranes, Zmatrix™ porcine peritoneum collagen membranes, Cytoplast™ PTFE suture, NovaBone® synthetic putty, the Pro-fix™ Precision Fixation System, and Resorba® dental sutures.

Committed to Quality & Customer Service

We pride ourselves in having the best customer service in the industry. Whether it’s placing an order or inquiring about a technical issue, you will always be greeted by a friendly voice who will work to quickly address your needs. Please note that online orders are for U.S. and Canadian customers only. For international orders, please contact us directly or visit our Global Network page to find a distributor.

25 Years of Innovation and Refinement

|

|

|

|

|

|

|

|

|

|

|

|

|

|

|

|

|

|

|

|

|

|

|

|

|

|

|

1996

Osteogenics Biomedical enters the dental bone grafting market with a dense PTFE membrane. The company is incorporated with a mission of developing dental bone grafting products to increase the predictability of regenerative procedures.

1998

Osteogenics introduces a new patented surface technology - the Regentexâ„¢ textured surface - to the dense PTFE membrane. This 3rd generation PTFE membrane combines the benefits of a membrane occlusive to bacteria with a textured surface that helps stabilize the membrane and soft tissue flap.

1999

Osteogenics introduces the first nitride-coated ridge augmentation mesh - Osteo-Meshâ„¢ TM-300.

1999

Osteogenics acquires Permaridge® synthetic ridge augmentation matrix from CeraMed Dental. Permaridge® helps correct alveolar ridge resorption, providing denture wearers with more stable and comfortable dentures.

1999

Osteogenics relocates to a larger manufacturing facility in Lubbock, TX.

2000

Osteogenics receives a technique patent for treating alveolar bone defects using dense PTFE membranes - the Cytoplast Techniqueâ„¢. The Cytoplast Techniqueâ„¢ for socket grafting is the first technique utilizing membranes left exposed, thereby reducing surgical time, preserving soft tissue architecture and increasing keratinzed mucosa. Because the Cytoplastâ„¢ dense PTFE membranes are impervious to bacteria, they are especially well-suited to be left exposed in the oral environment.

2002


Osteogenics expands its regenerative portfolio with the addition of Cytoplastâ„¢ PTFE Suture and Cytoplastâ„¢ RTM collagen membranes. The company is one of only two companies in the world to manufacture PTFE suture.

2003


Osteogenics receives ISO 9001 and ISO 13485 quality certifications, demonstrating compliance with strict European quality guidelines.

2005


Osteogenics moves its corporate headquarters and manufacturing operations into a new 7,000 square-foot state-of-the-art facility in Lubbock, TX..

2007


The company receives MDD/93/42/EEC certification, allowing the company to expand into Europe by distributing under the CE mark.

2007


The company applies its Regentexâ„¢ surfaced technology to its line of titanium-reinforced membranes. Osteogenics also introduces four new titanium-reinforced application-specific membrane sizes.

2008


Osteogenics Clinical Educationâ„¢, a division of Osteogenics Biomedical, is established with a mission of providing interactive, hands-on clinical education in bone grafting and implant dentistry.

2009


Osteogenics introduces two application-specific titanium-reinforced membrane sizes. The new sizes are the first to incorporate pilot holes and a broader titanium frame.

2009


170 clinicians from six countries and three continents attend Osteogenics Clinical Education'sâ„¢ first global bone grafting symposium in Scottsdale, Arizona.

2010


Osteogenics signs an agreement with META Advanced Medical Technology in Italy, giving the company distribution rights in the U.S. and Canada for its dental bone grafting products, including its autogenous bone collectors Micross and Safescraper®, and crestal sinus lift kit, SinCrest.

2010


Osteogenics introduces the Pro-fixâ„¢ Precision Fixation System. Pro-fixâ„¢ is first introduced with self-drilling membrane fixation screws and will soon include self-drilling tenting screws and self-tapping bone fixation screws.

2010


Osteogenics introduces enCore® Combination Allograft and enCore® Mineralized Allograft, the first dental bone grafting product introduced by Osteogenics. The combination allograft is the first particulate dental bone grafting product to combine mineralized and demineralized bone in a single bottle.

2012


Osteogenics moves into a new 10,000 square-foot manufacturing facility, adding to its corporate headquarters campus in Lubbock, Texas.

2014


Osteogenics undergoes major renovations to its corporate headquarters to maximize space for company growth.

2015


Osteogenics acquires exclusive distribution rights to sell the synthetic, osteostimulative NovaBone® Dental products in the U.S. and Canada. Within the NovaBone® product line is an especially unique product, NovaBone® Dental Putty, a pre-mixed moldable putty that is available in a variety of delivery systems.

2015


Osteogenics introduces Zcore™ porcine xenograft particulate, an osteoconductive anorganic bone mineral derived from porcine cancellous bone. Hyper-porosity of the porcine cancellous matrix and intra-particle space reduces bulk density of the graft, allowing 88 – 95% empty space for bone growth.

2016


Osteogenics acquires the exclusive North American distribution rights for the premium German dental suture brand, Resorba®. Resorba® sutures are made from unique materials that are designed especially for dentistry and are available with black 300-series stainless steel needles that enhance visualization in the mouth.

2016


Osteogenics introduces the newest product to complement the family of enCore® allografts - enCore® OD allograft, comprised of 30% mineralized cortical bone and 70% mineralized cancellous bone. enCore® OD is designed to be used with osseodensification (OD) protocols.

2016


Osteogenics expands its regenerative portfolio with the addition of absorbable collagen wound dressings - Cytoplastâ„¢ RTMPlug, RTMFoam, and RTMTape.

2018


Osteogenics launches its newest collagen membrane, Zmatrix, a natural/native non-cross-linked porcine peritoneum collagen membrane that is pliable enough to contour to its environment but substantial enough to not adhere to itself.

2018


RPMâ„¢ Reinforced PTFE Mesh is introduced. Its unique circular macroporous design allows for direct contact between the bone graft and periosteum, allowing

2020


Osteogenics acquires distribution rights for the Swann-Morton® premium micro-serrated blades. These blades are designed with a unique cutting edge that results in a consistently sharp blade. The edge design combines a micro-serrated edge with a razor edge that provides the user with a tactile sensitivity improving depth control, while also creating equal, smooth tissue margins.

Current Employment Opportunities

We are looking for the best and brightest minds to join our team. Browse our list of current job and internship opportunities, and electronically submit your resume using the form provided.

See Positions

Osteogenics Global Distribution Network

Find a Distributor

No Data Found
Customer Service & Technical Assistance
US AND CANADA
Outside US AND CANADA
7:00 AM to 7:00 PM CST, Monday - Thursday
7:00 AM to 5:00 PM CST, Friday
MAKE A PAYMENT
Facebook-f Linkedin-in Instagram Youtube

Products

Procedures

Copyright © 2025 Osteogenics Biomedical, All rights reserved

Design and Developed by devoqdesign

Shane Shuttlesworth

Shane Shuttlesworth was named president in October 2007. Prior to this position, Shane was the director of marketing & operations. Prior to assuming that position, he served several management positions in regulatory affairs, quality assurance and production. His current responsibilities include overseeing operations, marketing/sales, international business development, quality assurance and regulatory affairs. He originally joined Osteogenics Biomedical in 2001 as production manager.
A native of Lubbock, TX, Shane graduated summa cum laude with a bachelor of science degree in biology from Lubbock Christian University in 2001, received an MBA in general business and an advanced certificate in health organization management from Texas Tech University in 2003, and received a masters of science in regulatory affairs and services from St. Cloud State University in 2015.
Shane currently serves on Lubbock Christian University’s Young Alumni Advisory Board. Outside interests include basketball, football, fly fishing, and spending time with his daughter.

Liz Bastian

Liz Bastian joined Osteogenics in May 2021 as Director of Regulatory Affairs. In this role, she oversees all aspects and operations of the regulatory department.
Liz was born and raised in India. She moved to United Arab Emirates (UAE) in 2009 and then to Toronto, Canada in 2011. Several years later, she moved to Chicago, IL for her previous job, and she just recently moved to Lubbock, TX, where Osteogenics’ headquarters is located.
Prior to joining Osteogenics, Liz has worked for several medical device manufacturers and pharmaceutical companies as a regulatory affairs professional. She holds a bachelors and a masters degree in biotechnology and obtained her PMP certification in 2016.
Liz enjoys cooking, spending time with her husband and son, and traveling.

Blake Baucum

Blake Baucum was named director of sales in February 2022 after serving as the associate director of sales for five years and a regenerative product specialist for five years prior to that. His current responsibilities include overseeing sales activities, training the sales and marketing staff on the technical aspects of Osteogenics’ products, and supporting the marketing and regulatory teams in various projects.
Blake was born and raised in Lubbock, TX, and graduated from Texas Tech University in 2009 with a bachelor of science degree in biology. While attending Texas Tech, and for a short time after graduating, Blake worked at a local orthodontist’s office, filling various roles within the practice. He then took a position selling capital equipment for a larger dental supply company.
Blake cherishes spending time with his wife, two sons, and his extended family. He is an avid golfer, enjoys traveling, and loves spending time in the outdoors fly fishing or camping.

Courtney Riggan

Courtney Riggan was named director of engineering in July 2016 after serving as senior engineering manager for two and a half years and quality engineer for three years prior to that. Her current responsibilities include overseeing design & development, risk management, complaint management, and some regulatory submissions.
Born and raised in Lubbock, TX, Courtney graduated from Texas A&M University in 2008 with a bachelor of science degree in biomedical engineering and received an M.S. in mechanical engineering from Texas Tech University in 2010.
Courtney enjoys traveling, playing Frisbee golf, and spending time with her husband and two children.

Russ Rowan

Russ Rowan returned to Osteogenics as director of marketing in January 2024. He previously served as Ostoegenics’ director of marketing from 2012 – 2022 and spent a short time working in another industry during most of 2023. Throughout his career at Osteogenics, Russ has been an integral part of the company’s sales and marketing activities. Russ has had the opportunity to work on projects with various teams across different departments inside and outside the commercial part of the business.
Russ was born and raised in Lubbock, TX, and graduated from Texas Tech University in 2002 with an undergraduate degree in finance. He also received an executive MBA from Texas Tech in 2016.
Russ enjoys spending time with his family and getting a round of golf in whenever time allows.

Salem O'steen

Salem O’Steen was named Director of Quality Assurance in December 2023 after serving as the Associate Director of Quality Assurance for seven years and as a quality manager for nine years prior to that. His current responsibilities include overseeing all quality management system processes such as CAPA, document control, internal and external audits, management review, finished product release, and continuous quality system improvements. He originally joined Osteogenics Biomedical in 2005 as a production associate.
Salem is native to Lubbock, TX, and graduated with a bachelor of science degree in biology from Lubbock Christian University in 2005. Salem obtained a certification from American Association of Tissue Banks as a Certified Tissue Bank Specialist (CTBS) in 2009; he has a Six Sigma Green Belt certification; and he received a masters of science in medical technology in quality from St. Cloud State University in 2017.
Salem’s outside interests include cooking, exercising, camping, and spending time with his wife and two kids.

Evan Cain

Evan Cain was named Director of Research and Development in 2023. Prior to this position, Evan was the Associate Director of Research and Development since 2018. Evan originally began his career with Osteogenics in 2012 as a quality manager. His current responsibilities include overseeing the research and development of new products and product line improvement. Evan works closely with quality, regulatory, and operations teams to bring new products to market.
A native of Plains, TX, Evan graduated magna cum laude with a bachelor of science degree in chemistry from Texas Tech University in 2010. He then went on to receive a masters of science degree in biotechnology from Texas Tech University in 2013.
In his free time, Evan enjoys bass fishing, golfing, and spending time with his wife and two kids.

Anibal Manzo

Anibal Manzo joined Osteogenics in November 2023 as Director of Chanel Sales, where he is responsible for overseeing, supporting, and developing Osteogenics channel partners and global distribution network. Before joining Osteogenics, Anibal held several sales and marketing leadership roles at various U.S.-based dental companies. Most recently, he served as the VP of Sales and Marketing for the dental division at NovaBone Products, a position he held for three years.
Anibal was born in Caracas, Venezuela, and graduated from the Universidad Simon Bolivar in 1996 with a degree in International Business. He also earned a B.S. in Business from the Universidad Simon Rodriguez in 2000. Anibal moved to the United States in 2001, continuing his career in marketing and internal business within the dental implant industry.

Anibal values spending time with his wife and daughter. He enjoys outdoor activities, cooking, exercising, cycling, and traveling.